Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Feb;41(2):302–304. doi: 10.1038/bjc.1980.43

Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.

P Workman, N M Bleehen, C R Wiltshire
PMCID: PMC2010192  PMID: 7370170

Full text

PDF
302

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ash D. V., Smith M. R., Bugden R. D. Distribution of misonidazole in human tumours and normal tissues. Br J Cancer. 1979 May;39(5):503–509. doi: 10.1038/bjc.1979.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  3. Dische S., Saunders M. I., Lee M. E., Adams G. E., Flockhart I. R. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977 May;35(5):567–579. doi: 10.1038/bjc.1977.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hall E. J., Roizin-Towle L. Hypoxic sensitizers: radiobiological studies at the cellular level. Radiology. 1975 Nov;117(2):453–457. doi: 10.1148/117.2.453. [DOI] [PubMed] [Google Scholar]
  5. McNally N. J., Denekamp J., Sheldon P., Flockhart I. R., Stewart F. A. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. Radiat Res. 1978 Mar;73(3):568–580. [PubMed] [Google Scholar]
  6. Pirttiaho H. I., Sotaniemi E. A., Ahokas J. T., Pitkänen U. Liver size and indices of drug metabolism in epileptics. Br J Clin Pharmacol. 1978 Sep;6(3):273–278. doi: 10.1111/j.1365-2125.1978.tb04597.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Saunders M. E., Dische S., Anderson P., Flockhart I. R. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum. Br J Cancer Suppl. 1978 Jun;3:268–270. [PMC free article] [PubMed] [Google Scholar]
  8. Stratford I. J., Adams G. E. The toxicity of the radiosensitizer misonidazole towards hypoxic cells in vitro: a model for mouse and man. Br J Radiol. 1978 Sep;51(609):745–746. doi: 10.1259/0007-1285-51-609-745. [DOI] [PubMed] [Google Scholar]
  9. Urtasun R. C., Chapman J. D., Feldstein M. L., Band R. P., Rabin H. R., Wilson A. F., Marynowski B., Starreveld E., Shnitka T. Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer Suppl. 1978 Jun;3:271–275. [PMC free article] [PubMed] [Google Scholar]
  10. Workman P. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Br J Cancer. 1979 Sep;40(3):335–353. doi: 10.1038/bjc.1979.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Workman P., Little C. J., Marten T. R., Dale A. D., Ruane R. J., Flockhart I. R., Bleehen N. M. Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography. J Chromatogr. 1978 May 1;145(3):507–512. doi: 10.1016/s0378-4347(00)81386-9. [DOI] [PubMed] [Google Scholar]
  12. Workman P., Wiltshire C. R., Plowman P. N., Bleehen N. M. Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring. Br J Cancer. 1978 Dec;38(6):709–718. doi: 10.1038/bjc.1978.277. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES